Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
DXJW9A
|
||||
| Drug Name |
4-(5-amino-1-(pyridin-2-yl)-1H-1,2,4-triazol-3-ylamino)-N-(2-morpholinoethyl)benzamide
|
||||
| Synonyms |
CHEMBL1835749
|
||||
| Indication | Discovery agent | Investigative | [1587926] | ||
| Formula |
C20H24N8O2
|
||||
| Canonical SMILES |
Nc1nc(Nc2ccc(cc2)C(=O)NCCN3CCOCC3)nn1c4ccccn4
|
||||
| InChI |
InChI=1S/C20H24N8O2/c21-19-25-20(26-28(19)17-3-1-2-8-22-17)24-16-6-4-15(5-7-16)18(29)23-9-10-27-11-13-30-14-12-27/h1-8H,9-14H2,(H,23,29)(H3,21,24,25,26)
|
||||
| InChIKey |
CNWWATUNBGEOQE-UHFFFAOYSA-N
|
||||
| Target and Pathway | |||||
| Target(s) | FL cytokine receptor | Target Info | [1587926] | ||
| Mast/stem cell growth factor receptor | Target Info | [1587926] | |||
| KEGG Pathway | Cytokine-cytokine receptor interaction | ||||
| Hematopoietic cell lineage | |||||
| Pathways in cancer | |||||
| Transcriptional misregulation in cancer | |||||
| Acute myeloid leukemia | |||||
| Central carbon metabolism in cancerhsa04014:Ras signaling pathway | |||||
| Rap1 signaling pathway | |||||
| Endocytosis | |||||
| PI3K-Akt signaling pathway | |||||
| Melanogenesis | |||||
| Central carbon metabolism in cancer | |||||
| Pathway Interaction Database | C-MYB transcription factor network | ||||
| Signaling events mediated by Stem cell factor receptor (c-Kit) | |||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.